NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-250-2014-0-IT-01 Anti-CD276 Antibodies (B7H3) IT EP 15772128.3 Issued
NCI E-250-2014-0-DE-01 Anti-CD276 Antibodies (B7H3) DE EP 15772128.3 Issued
NCI E-250-2014-0-FR-01 Anti-CD276 Antibodies (B7H3) FR EP 15772128.3 Issued
NCI E-250-2014-0-GB-01 Anti-CD276 Antibodies (B7H3) GB EP 15772128.3 Issued
NCI E-250-2014-0-EP-06 Anti-CD276 Antibodies (B7H3) EP National Stage 15772128.3 Issued
NCI E-250-2014-0-JP-05 ANTI-CD276 ANTIBODIES (B7H3) JP National Stage 2017-514697 Issued
NIAAA E-316-2013-0-ID-09 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate ID National Stage P00201505839 Abandoned
NIAAA E-316-2013-0-SG-13 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate SG National Stage 11201507685U Abandoned
NCI E-250-2014-0-PCT-02 ANTI-CD276 ANTIBODIES (B7H3) PCT PCT PCT/US2015/050365 Expired
NHLBI E-284-2015-0-US-01 Segmented Braided MRI Catheter US 62/219,472 Abandoned
NIAID E-117-2013-1-US-04 Epitope of RSV Fusion Protein and Antibody Identifying Same US National Stage 14/777,275 9856313 Issued PDF
NCI E-033-2013-1-US-04 Stabilized Single Human CD4 Domains And Fusion Proteins US National Stage 14/777,245 Abandoned
NCI E-265-2015-0-US-01 T-cell Receptors Recognizing HLA-CW8 Restricted Mutated KRAS US 62/218,688 Abandoned
NHLBI E-287-2015-0-US-01 Device, Prosthesis And Delivery Systems, Transcatheter MRI-guided Implantable Cavopulmonary Bypass Endograft US 62/219,118 Abandoned
NCI E-269-2015-0-US-01 METHODS OF ISOLATING TUMOR-REACTIVE T CELL RECEPTORS FROM TUMOR OR PERIPHERAL BLOOD US 62/218,763 Abandoned
NIAID E-081-2013-4-KR-09 Prefusion RSV F Proteins And Their Use KR National Stage 10-2015-7025199 Issued
NIAID E-117-2013-1-JP-08 Epitope of RSV Fusion Protein and Antibody Identifying Same JP National Stage 2015-561931 Issued
NCI E-094-2013-0-US-03 Peptide And Peptide Mimetic Binding Antagonists Of Polo-like Kinase 1 Polo Box Domain And Methods Of Use US National Stage 14/776,512 10047122 Issued PDF
NIAID E-081-2013-4-US-12 Prefusion RSV F Proteins and Their Use US National Stage 14/776,651 10017543 Issued PDF
NHLBI E-027-2013-0-US-04 Devices and Methods for Treating Functional Tricuspid Valve Regurgitation US National Stage 14/776,488 9987135 Issued PDF
NHGRI E-060-2013-0-US-03 Compositions and Methods for Predicting Age of Onset of a Lysosomal Storage Disease or a Disease Associated with a Lysosomal Defect US National Stage 14/776,440 9983200 Issued PDF
NCI E-065-2013-0-US-03 FKBP52 TARGETING AGENT PHARMACEUTICAL COMPOSITIONS US National Stage 14/775,822 Abandoned
NCI E-296-2011-0-US-06 Methods for Modulating Chemotherapeutic Cytotoxicity US National Stage 14/775,428 11285169 Issued PDF
NIAAA E-049-2016-0-US-08 COMPOUND FOR USE IN PROTECTING SKIN US National Stage 14/774,856 10821062 Issued PDF
NIAID E-117-2013-1-CN-02 EPITOPE OF RSV FUSION PROTEIN AND ANTIBODY RECOGNIZING THE EPITOPE CN National Stage 201480013927.7 Issued
NCI E-111-2013-0-US-04 Tetrahydroxamate Chelators of Zirconium89 and Niobium90 for Use in Diagnostic Applications US National Stage 14/774,831 10137212 Issued PDF
CC E-184-2012-0-JP-04 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging JP National Stage 2016-502420 Issued
NIAAA E-316-2013-0-JP-11 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate JP National Stage 2015-562212 Abandoned
NCATS E-023-2013-0-US-03 NRF2 Small Molecule Inhibitors for Cancer Therapy US National Stage 14/774,956 Abandoned
NHGRI E-056-2013-0-US-05 Hyposialylation Disorders US National Stage 14/775,507 Abandoned
NCATS E-300-2012-0-US-02 Coincidence Reporter Gene System US National Stage 14/775,293 Abandoned
NCI E-059-2013-0-RU-08 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor RU National Stage 2015138483 Issued
NINDS E-301-2007-0-US-17 Transcranial Magnetic Stimulation System And Methods US CON 14/849,632 10029113 Expired PDF
NCI E-203-2000-0-US-14 Biologically Active Macrolides, Compositions, and Uses Thereof US CON 14/849,798 9820965 Abandoned PDF
NCI E-035-2013-0-US-03 Inhibitors Of The Linear Ubiquitin Chain Assembly Complex (LUBAC) and Related Methods US National Stage 14/774,478 9783586 Issued PDF
NCI E-243-2015-0-US-01 ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS US 62/216,447 Abandoned
NCI E-106-2014-0-IL-09 YEAST-BASED IMMUNOTHERAPY FOR CHORDOMA IL National Stage 241384 Issued
NHGRI E-243-2012-0-US-04 Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) US National Stage 14/773,885 9719080 Issued PDF
NIAID E-185-2015-0-US-01 EXPRESSION VECTOR DELIVERY PLATFORM AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE US 62/215,927 Abandoned
CC E-026-2015-0-US-01 SYSTEM AND METHOD FOR PLANNING AND PERFORMING A REPEAT INTERVENTIONAL PROCEDURE US 62/215,775 Abandoned
NINDS E-251-2005-2-CA-04 SYSTEMS AND METHODS FOR RECOVERY FROM MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA CA National Stage 2737478 Issued
NEI E-212-2015-0-US-01 Method for Reproducible Differentiation of Clinical-Grade Retinal Pigment Epithelium Cells US 62/215,579 Abandoned
NIAID E-178-2014-2-EP-03 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE EP National Stage 15766697.5 Issued
NIAID E-178-2014-2-GB-09 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE GB EP 15766697.5 Issued
NIAID E-178-2014-2-DE-07 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE DE EP 15766697.5 Issued
NIAID E-178-2014-2-IE-10 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE IE EP 15766697.5 Issued
NIAID E-178-2014-2-BE-05 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE BE EP 15766697.5 Issued
NIAID E-178-2014-2-CH-06 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE CH EP 15766697.5 Issued
NIAID E-178-2014-2-FR-08 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE FR EP 15766697.5 Issued
NCI E-269-2009-0-CA-04 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity CA National Stage 2773665 Issued